Justin L. Anglin

1.2k total citations
16 papers, 909 citations indexed

About

Justin L. Anglin is a scholar working on Molecular Biology, Cancer Research and Biochemistry. According to data from OpenAlex, Justin L. Anglin has authored 16 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Biochemistry. Recurrent topics in Justin L. Anglin's work include Epigenetics and DNA Methylation (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Cancer-related gene regulation (4 papers). Justin L. Anglin is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Cancer-related gene regulation (4 papers). Justin L. Anglin collaborates with scholars based in United States, Australia and United Kingdom. Justin L. Anglin's co-authors include Yongcheng Song, Yuan Yao, Lisheng Deng, B. V. Venkataram Prasad, Luke L. Lairson, Pinhong Chen, Gang Cheng, Costas A. Lyssiotis, Lewis C. Cantley and Reza Beheshti Zavareh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and The Journal of Experimental Medicine.

In The Last Decade

Justin L. Anglin

16 papers receiving 892 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Justin L. Anglin United States 13 700 240 97 87 70 16 909
Reza Beheshti Zavareh United States 12 626 0.9× 254 1.1× 88 0.9× 60 0.7× 242 3.5× 15 929
Janis de la Iglesia-Vicente Spain 15 592 0.8× 181 0.8× 45 0.5× 24 0.3× 214 3.1× 19 1.0k
Tammy L. Bush United States 14 497 0.7× 55 0.2× 84 0.9× 21 0.2× 156 2.2× 30 750
Sascha Menninger Germany 11 929 1.3× 52 0.2× 23 0.2× 42 0.5× 111 1.6× 19 1.3k
Enrico Girardi United States 24 461 0.7× 54 0.2× 63 0.6× 37 0.4× 238 3.4× 37 1.5k
Gabriela Galicia-Vázquez Canada 13 837 1.2× 176 0.7× 29 0.3× 47 0.5× 176 2.5× 16 1.3k
J.J. Keusch Switzerland 17 795 1.1× 59 0.2× 19 0.2× 56 0.6× 171 2.4× 22 1.1k
Barbara Saxty United Kingdom 16 689 1.0× 134 0.6× 26 0.3× 26 0.3× 201 2.9× 33 1.1k
Verónica Alcolea Spain 12 342 0.5× 100 0.4× 13 0.1× 236 2.7× 73 1.0× 19 851
Shukie Ng Singapore 11 453 0.6× 114 0.5× 23 0.2× 24 0.3× 111 1.6× 11 737

Countries citing papers authored by Justin L. Anglin

Since Specialization
Citations

This map shows the geographic impact of Justin L. Anglin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin L. Anglin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin L. Anglin more than expected).

Fields of papers citing papers by Justin L. Anglin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justin L. Anglin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin L. Anglin. The network helps show where Justin L. Anglin may publish in the future.

Co-authorship network of co-authors of Justin L. Anglin

This figure shows the co-authorship network connecting the top 25 collaborators of Justin L. Anglin. A scholar is included among the top collaborators of Justin L. Anglin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justin L. Anglin. Justin L. Anglin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Modukuri, Ram K., Zhifeng Yu, Zhi Tan, et al.. (2022). Discovery of potent BET bromodomain 1 stereoselective inhibitors using DNA-encoded chemical library selections. Proceedings of the National Academy of Sciences. 119(22). e2122506119–e2122506119. 27 indexed citations
2.
Yu, Zhifeng, Justin L. Anglin, Rajesh Sharma, et al.. (2021). Discovery and characterization of bromodomain 2–specific inhibitors of BRDT. Proceedings of the National Academy of Sciences. 118(9). 49 indexed citations
3.
Anglin, Justin L., Liya Hu, Lingfei Wang, et al.. (2021). Unique Diacidic Fragments Inhibit the OXA-48 Carbapenemase and Enhance the Killing of Escherichia coli Producing OXA-48. ACS Infectious Diseases. 7(12). 3345–3354. 5 indexed citations
4.
Anglin, Justin L., Melek N. Ucisik, John C. Faver, et al.. (2020). Identifying Oxacillinase-48 Carbapenemase Inhibitors Using DNA-Encoded Chemical Libraries. ACS Infectious Diseases. 6(5). 1214–1227. 31 indexed citations
5.
Lucki, Natasha C., Genaro R. Villa, Michael J. Bollong, et al.. (2019). A cell type-selective apoptosis-inducing small molecule for the treatment of brain cancer. Proceedings of the National Academy of Sciences. 116(13). 6435–6440. 25 indexed citations
6.
Holt, Melissa C., Reza Beheshti Zavareh, Lin Lin, et al.. (2018). Biochemical Characterization and Structure-Based Mutational Analysis Provide Insight into the Binding and Mechanism of Action of Novel Aspartate Aminotransferase Inhibitors. Biochemistry. 57(47). 6604–6614. 27 indexed citations
7.
Anglin, Justin L., Reza Beheshti Zavareh, Philipp N. Sander, et al.. (2018). Discovery and optimization of aspartate aminotransferase 1 inhibitors to target redox balance in pancreatic ductal adenocarcinoma. Bioorganic & Medicinal Chemistry Letters. 28(16). 2675–2678. 29 indexed citations
8.
Lum, Kenneth M., et al.. (2017). Mapping Protein Targets of Bioactive Small Molecules Using Lipid-Based Chemical Proteomics. ACS Chemical Biology. 12(10). 2671–2681. 27 indexed citations
9.
Mullarky, Edouard, Natasha C. Lucki, Reza Beheshti Zavareh, et al.. (2016). Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers. Proceedings of the National Academy of Sciences. 113(7). 1778–1783. 251 indexed citations
10.
Zheng, Baisong, Yuan Yao, Zhen Liu, et al.. (2013). Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate Dehydrogenase. ACS Medicinal Chemistry Letters. 4(6). 542–546. 56 indexed citations
11.
Anglin, Justin L. & Yongcheng Song. (2013). A Medicinal Chemistry Perspective for Targeting Histone H3 Lysine-79 Methyltransferase DOT1L. Journal of Medicinal Chemistry. 56(22). 8972–8983. 63 indexed citations
12.
Anglin, Justin L., Lisheng Deng, Yuan Yao, et al.. (2012). Synthesis and Structure–Activity Relationship Investigation of Adenosine-Containing Inhibitors of Histone Methyltransferase DOT1L. Journal of Medicinal Chemistry. 55(18). 8066–8074. 74 indexed citations
13.
Nair, Sethu C., Carrie F. Brooks, C.D. Goodman, et al.. (2012). Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondii. The Journal of Experimental Medicine. 209(5). 1051–1051. 1 indexed citations
14.
Yao, Yuan, Pinhong Chen, Jiasheng Diao, et al.. (2012). Correction to Selective Inhibitors of Histone Methyltransferase DOT1L: Design, Synthesis, and Crystallographic Studies. Journal of the American Chemical Society. 134(42). 17834–17834. 4 indexed citations
15.
Nair, Sethu C., Carrie F. Brooks, C.D. Goodman, et al.. (2011). Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondii. The Journal of Experimental Medicine. 208(7). 1547–1559. 118 indexed citations
16.
Yao, Yuan, Pinhong Chen, Jiasheng Diao, et al.. (2011). Selective Inhibitors of Histone Methyltransferase DOT1L: Design, Synthesis, and Crystallographic Studies. Journal of the American Chemical Society. 133(42). 16746–16749. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Reza Beheshti Zavareh Breakdown of academic impact, for papers by Janis de la Iglesia-Vicente Breakdown of academic impact, for papers by Tammy L. Bush Breakdown of academic impact, for papers by Sascha Menninger Breakdown of academic impact, for papers by Enrico Girardi Breakdown of academic impact, for papers by Gabriela Galicia-Vázquez Breakdown of academic impact, for papers by J.J. Keusch Breakdown of academic impact, for papers by Barbara Saxty Breakdown of academic impact, for papers by Verónica Alcolea Breakdown of academic impact, for papers by Shukie Ng
Rankless by CCL
2026